FDA Office of Orphan Products Development

NCT06080074

Collaborator, Phase 2, Recruiting, 2025, 50 people, 12 Oct 2023, clinicaltrials.gov

NCT04170348

Collaborator, Phase 2, Completed, 2020, 58 people, 20 Nov 2019, clinicaltrials.gov

NCT02471911

Collaborator, Phase 1, Completed, 2015, 22 people, 15 Jun 2015, clinicaltrials.gov

NCT01527032

Phase 2, Completed, 2002, 6 Feb 2012, clinicaltrials.gov

NCT00730236

Collaborator, Phase 3, Completed, 2007, 29 people, 8 Aug 2008, clinicaltrials.gov

NCT00555464

Collaborator, Phase 2, Terminated, 2007, 8 people, 8 Nov 2007, clinicaltrials.gov

NCT00529191

Collaborator, Phase 2, Completed, 2007, 40 people, 14 Sept 2007, clinicaltrials.gov

NCT00508027

Collaborator, Phase 1/2, Completed, 2007, 42 people, 27 Jul 2007, clinicaltrials.gov

NCT00432744

Collaborator, Phase 3, Completed, 2007, 24 people, 8 Feb 2007, clinicaltrials.gov

NCT00429364

Collaborator, Phase 3, Completed, 2007, 608 people, 31 Jan 2007, clinicaltrials.gov

NCT00414648

Collaborator, Phase 3, Completed, 2006, 89 people, 21 Dec 2006, clinicaltrials.gov

NCT00277355

Collaborator, Phase 2/3, Completed, 2006, 114 people, 16 Jan 2006, clinicaltrials.gov

NCT00259857

Collaborator, Phase 2, Completed, 2003, 22 people, 1 Dec 2005, clinicaltrials.gov

NCT00125788

Collaborator, Phase 2, Completed, 2004, 70 people, 2 Aug 2005, clinicaltrials.gov

NCT00057408

Phase 2, Completed, 2003, 78 people, 2 Apr 2003, clinicaltrials.gov

NCT00029874

Phase 1/2, Completed, 2001, 63 people, 25 Jan 2002, clinicaltrials.gov

NCT00004402

Phase 3, Completed, 1999, 30 people, 19 Oct 1999, clinicaltrials.gov